• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Report: Amazon abandons drug distribution and supply plans

April 18, 2018 By Fink Densford

Amazon

Amazon‘s (NSDQ:AMZN) Business division has dropped plans to sell and distribute pharmaceutical products to hospitals, according to a new report from CNBC.

The shift comes due to the online mega-retailer being unable to convince large hospital groups to change their purchasing process and break existing deals and relationships with distributors, according to the report.

The transition to operating as a pharmaceutical supplier would also require Amazon to develop advanced logistics networks and the ability to handle temperature-sensitive pharmaceuticals, according to the CNBC report, which references individuals familiar with the deal.

The online retailer will reportedly continue with its plans to deliver basic medical supplies to hospitals and smaller clinics through its Amazon Business division. In February, the Wall Street Journal reported that Amazon was looking to up its stake in its hospital supplies offerings, providing products to approximately 150 outpatient facilities and hospitals.

Amazon may not be completely out of the pharmaceutical business, with multiple sources speculating that the company could be considering a direct-to-consumer prescription drug biz, according to the report.

In March, Amazon showed it is still invested in increasing its stake in the healthcare industry by picking up former FDA chief health informatics officer Taha Kass-Hout.

Filed Under: Business/Financial News, Distribution, Featured, Pharmaceuticals Tagged With: amazon

IN CASE YOU MISSED IT

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Glucotrack can proceed with long-term glucose monitor study in Australia
  • Dexcom promotes Jake Leach to president role
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS